Literature DB >> 11746147

Pathophysiology, diagnosis and management of prenatal upper tract dilatation.

P D Mouriquand1, M Whitten, J P Pracros.   

Abstract

Upper tract dilatation presenting as renal pelvis dilatation with or without ureteric dilatation is one of the more common abnormalities detected on prenatal ultrasound scanning. The majority of cases are due to pelvi-ureteric and vesico-ureteric junction anomalies, and vesico-ureteric reflux. Prenatal diagnosis with ultrasound may be aided by biochemical analysis of fetal blood and urine. The natural history of prenatally detected abnormalities remains under review. Precise diagnosis, and therefore prognosis, may not be made until after birth. Copyright 2001 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2001        PMID: 11746147

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  5 in total

1.  Current management of infants with fetal renal pelvis dilation: a survey by French-speaking pediatric nephrologists and urologists.

Authors:  Khalid Ismaili; Fred E Avni; Amy Piepsz; Karl M Wissing; Pierre Cochat; Didier Aubert; Michelle Hall
Journal:  Pediatr Nephrol       Date:  2004-07-06       Impact factor: 3.714

Review 2.  [MRI of the fetal abdomen].

Authors:  M Hörmann; P C Brugger; L Witzani; D Prayer
Journal:  Radiologe       Date:  2006-02       Impact factor: 0.635

3.  The antenatally detected pelvi-ureteric junction stenosis: advances in renography and strategy of management.

Authors:  Khalid Ismaili; Amy Piepsz
Journal:  Pediatr Radiol       Date:  2013-03-24

4.  [Ultrasound screening and follow-up study of congenital anomalies of the kidney and urinary tract in neonates].

Authors:  N N Li; L N Ji; S Chao; K Yuan; H Meng; Z Y Huang; H B Zhang
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-12-18

5.  Diagnosis of 65 cases of ampullary renal pelvis after postnatal follow-up of 1,167 newborn infants with prenatally suspected hydronephrosis.

Authors:  Lei Zhang; Chao Liu; Fujiang Li; Xiang Li; Chao Sun; Hao Sun
Journal:  Exp Ther Med       Date:  2014-11-18       Impact factor: 2.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.